Recall: Sodium Bicarbonate

Nov. 2022Pharmacy Updates
Exela Pharma Sciences LLC (Exela) has recalled 49 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial. This drug is used to treat a condition where there is too much acid in the body fluids. The product is packaged in a 50 mL glass vial. Read the full text of the Sodium Bicarbonate recall.

Recent Announcements

PA DOH Antibiotic Stewardship Resources

Order antibiotic stewardship resources at no cost
Jun. 2026Important Notices

Medical device correction: Omnipod (Insulet – May 2026)

Insulet Corporation Inc. has announced a medical device correction for certain Omnipod Pods. These pods are wearable devices that are used to deliver insulin.
Jun. 2026Pharmacy Updates

Clinical documentation required for medical policy prior authorizations

As you know, UPMC Health Plan requires certain clinical documentation/notes in support of a request for prior authorization for the listed procedures below in accordance with its established policies and procedures, in addition to CMS requirements that medical record documentation must support the medical necessity of the services requested.
Jun. 2026Important Notices